跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
METHYLPREDNISOLONE POWDER FOR SOLUTION FOR INJECTION 500MG - HSA Drug Approval Details
Approvals
/
HSA
/
METHYLPREDNISOLONE POWDER FOR SOLUTION FOR INJECTION 500MG
Approved
THERAPEUTIC
METHYLPREDNISOLONE POWDER FOR SOLUTION FOR INJECTION 500MG
MYLAN LABORATORIES LIMITED [SPECIALTY FORMULATION FACILITY] (INDIA)
🇸🇬 Health Sciences Authority
Approval Date
Aug 26, 2014
Approval ID
42d560d733fb0e61
Company
MYLAN LABORATORIES LIMITED [SPECIALTY FORMULATION FACILITY] (INDIA)
Type
Therapeutic
Approval Details
Approval Id
42d560d733fb0e61
Drug Name
METHYLPREDNISOLONE POWDER FOR SOLUTION FOR INJECTION 500MG
Product Name
METHYLPREDNISOLONE POWDER FOR SOLUTION FOR INJECTION 500MG
Approval Number
SIN14594P
Approval Date
2014-08-26
Registrant
VIATRIS PHARMACEUTICALS PTE. LTD.
Licence Holder
VIATRIS PHARMACEUTICALS PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route Of Administration
INTRAVENOUS
Atc Code
H02AB04
Atc Item Name
methylprednisolone
Pharma Manufacturer Name
mylan pharmaceuticals pte. ltd.
Active Ingredients
Methylprednisolone sodium succinate 633.60mg equv Methylprednisolone
500mg
Methylprednisolone sodium succinate 633.60mg equv Methylprednisolone
500mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Aug 26, 2014
Approval ID
42d560d733fb0e61
Type
Therapeutic
Back to HSA Approvals
